scispace - formally typeset
F

François Coudoré

Researcher at Université Paris-Saclay

Publications -  59
Citations -  1894

François Coudoré is an academic researcher from Université Paris-Saclay. The author has contributed to research in topics: Peripheral neuropathy & Allodynia. The author has an hindex of 22, co-authored 59 publications receiving 1720 citations. Previous affiliations of François Coudoré include University of Paris-Sud & French Institute of Health and Medical Research.

Papers
More filters
Journal ArticleDOI

Does inhibition of P-glycoprotein lead to drug-drug interactions?

TL;DR: Concomitant administration of substrates and Pgp inhibitors would modify drug pharmacokinetics by increasing bioavailability and organ uptake, leading to more adverse drug reactions and toxicities.
Journal ArticleDOI

An animal model of nociceptive peripheral neuropathy following repeated cisplatin injections

TL;DR: This animal model of nociceptive neuropathy would be suitable to study the pathophysiologic mechanisms of neuropathic pain and to test potential neuroprotective agents.
Journal ArticleDOI

Behavioral and pharmacological description of oxaliplatin-induced painful neuropathy in rat

TL;DR: An animal model of nociceptive sensory neuropathy induced by repeat intravenous administration of oxali Platin in which treated animals partly reproduce the characteristic pain symptoms in oxaliplatin‐treated patients is described.
Journal ArticleDOI

Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.

TL;DR: A correlation between neurochemical and behavioral effects of [BDNF+SSRI] co-administration suggests that its antidepressant-like activity is linked to the activation of 5-HT neurotransmission in the adult hippocampus.
Journal ArticleDOI

Animal Models of Chemotherapy-Evoked Painful Peripheral Neuropathies

TL;DR: Improved understanding of the pathophysiology of chemotherapy-induced neurotoxicity need for animal models is clinically relevant and will assist in the development of future neuroprotective strategies and also in the design of novel chemotherapies with improved toxicity profiles.